South African-led Study Supports Use of Cepheid Test for Diagnosing TB in Children | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cepheid's Xpert MTB/RIF molecular test can detect pediatric tuberculosis cases more accurately than smear microscopy of sputum samples, according to a study in the early, online version of The Lancet Infectious Diseases today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.